Literature DB >> 10655281

Cholelithiasis and the insulin resistance syndrome.

A K Diehl.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10655281     DOI： 10.1002/hep.510310238

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  16 in total

Review 1.  Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Authors:  Eldon A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2005-05

2.  Gallstone disease and mortality: a cohort study.

Authors:  Daniel Mønsted Shabanzadeh; Lars Tue Sørensen; Torben Jørgensen
Journal:  Int J Public Health       Date:  2016-11-04       Impact factor: 3.380

3.  Metabolic syndrome as a risk factor for gallstone disease.

Authors:  Nahum Méndez-Sánchez; Norberto C Chavez-Tapia; Daniel Motola-Kuba; Karla Sanchez-Lara; Guadalupe Ponciano-Rodríguez; Héctor Baptista; Martha H Ramos; Misael Uribe
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Screen-detected gallstone disease and cardiovascular disease.

Authors:  Daniel Mønsted Shabanzadeh; Tea Skaaby; Lars Tue Sørensen; Torben Jørgensen
Journal:  Eur J Epidemiol       Date:  2017-05-27       Impact factor: 8.082

5.  A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.

Authors:  Sobha Puppala; Gerald D Dodd; Sharon Fowler; Rector Arya; Jennifer Schneider; Vidya S Farook; Richard Granato; Thomas D Dyer; Laura Almasy; Christopher P Jenkinson; Andrew K Diehl; Michael P Stern; John Blangero; Ravindranath Duggirala
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

6.  Vitamin D and gallstone disease-A population-based study.

Authors:  Daniel Mønsted Shabanzadeh; Torben Jørgensen; Allan Linneberg; Lars Tue Sørensen; Tea Skaaby
Journal:  Endocrine       Date:  2016-10-01       Impact factor: 3.633

7.  Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

Authors:  Antonio Ramos-De la Medina; José M Remes-Troche; Federico B Roesch-Dietlen; Alfonso G Pérez-Morales; Silvia Martinez; Silvia Cid-Juarez
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

8.  Hepatic insulin resistance directly promotes formation of cholesterol gallstones.

Authors:  Sudha B Biddinger; Joel T Haas; Bian B Yu; Olivier Bezy; Enxuan Jing; Wenwei Zhang; Terry G Unterman; Martin C Carey; C Ronald Kahn
Journal:  Nat Med       Date:  2008-06-29       Impact factor: 53.440

9.  Central adiposity, regional fat distribution, and the risk of cholecystectomy in women.

Authors:  C-J Tsai; M F Leitzmann; W C Willett; E L Giovannucci
Journal:  Gut       Date:  2006-02-14       Impact factor: 23.059

10.  Pancreatic function following post-endoscopic retrograde cholangiopancreatography pancreatitis: A controlled cohort study with long-term follow-up.

Authors:  Bonna Leerhøy; Daniel M Shabanzadeh; Andreas Nordholm-Carstensen; Srdan Novovic; Mark B Hansen; Lars N Jørgensen
Journal:  United European Gastroenterol J       Date:  2017-11-09       Impact factor: 4.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.